Healthcare's ascension to patient-centered genomic care

被引：4

作者：

Murphy, Steven A. R. ^{[1
]}

Freed, Jeffrey S. ^{[1
]}

机构：

[1] Helix Hlth LLC PLLC, New York, NY 10028 USA

来源：

PERSONALIZED MEDICINE | 2008年 / 5卷 / 05期

关键词：

BRCA; clinical genetics; corporate genomics; Helix Health; Institute of Medicine; patient-centered care; personalized medicine;

D O I：

10.2217/17410541.5.5.505

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The future of healthcare in the 21st century will be patient-centered genomic care. These two previously disparate fields now stand to help revolutionize the way in which we provide healthcare. Preventative medicine guided by genomic information and patient preference will enable further reductions in common chronic diseases, especially with the significant aging population. This care will increasingly involve corporate genomics companies and services to accomplish evidence-based medicine and patient-centered delivery. The goal of this advanced care should be 'the care we need and no less, the care we want and no more'. Armed with genomic knowledge and healthcare coaching, patients of the 21st century will be prepared to reduce disease burden and improve healthcare satisfaction through active partnerships with healthcare practitioners and complementary technology. Anything less cannot truly be patient-centered genomic medicine.

引用

页码：505 / 509

页数：5

共 14 条

[1]

Aspinall MG, 2007, HARVARD BUS REV, V85, P108

[2]

Blaine Sean M, 2008, J Genet Couns, V17, P189, DOI 10.1007/s10897-007-9142-z

[3] Cancer genetics evaluation: Barriers to and improvements for referral [J].